MC Form 4: Laila Worrell receives 2024/2025 dividend-equivalent RSUs

Q: When will these dividend-equivalent RSUs vest?

The dividend-equivalent RSUs will vest concurrently with the underlying RSUs to which they relate, per the filing.

Q: Who signed the Form 4 and when?

The Form is signed by Osamu Watanabe as attorney-in-fact for Laila Worrell on 09/19/2025 .

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Moelis & Co (MC) director Laila Worrell reported acquisitions of restricted stock units on 09/18/2025. The Form 4 shows three separate awards of dividend-equivalent RSUs tied to previously granted awards: 2024 Annual RSUs, 2025 Annual RSUs and 2025 Elective RSUs. Each RSU represents the right to receive one share of Class A common stock and the dividend-equivalent RSUs will vest concurrently with the underlying RSUs. The Form is signed by an attorney-in-fact on 09/19/2025.

Positive

Director received dividend-equivalent RSUs that maintain alignment with underlying long-term incentives
Each RSU converts to one share of Class A common stock, providing a clear equity linkage for compensation

Negative

None.

Insights

TL;DR: Director acquired dividend-equivalent RSUs that mirror existing awards and will vest with underlying grants.

The filing documents non-cash compensation activity rather than open-market trades. The awards are dividend-equivalent RSUs for 2024 Annual, 2025 Annual and 2025 Elective plans, each converting to one share of Class A common stock upon vesting. No dispositions, option exercises, or derivative transactions are reported. This is a routine insider compensation disclosure that increases the director's prospective share delivery contingent on vesting.

TL;DR: This Form 4 records standard dividend-equivalent RSU grants tied to existing awards; governance impact is limited.

The report indicates compensation mechanics rather than changes in control or material corporate events. The awards are explicitly described as dividend equivalents that vest with underlying awards, preserving alignment with shareholder interests while not reflecting immediate share issuance. Signature by an attorney-in-fact is noted, consistent with procedural filing practice.

Insider Trade Summary

Net Buyer: 46.28 shares

Net Buy 3 txns

Insider Worrell Laila

Role Director

Type	Security	Shares	Price	Value
Grant/Award	2024 Annual Restricted Stock Units	16.84	$0.00	$0.00
Grant/Award	2025 Annual Restricted Stock Units	14.05	$0.00	$0.00
Grant/Award	2025 Elective Restricted Stock Units	15.39	$0.00	$0.00

Holdings After Transaction: 2024 Annual Restricted Stock Units — 2,031.47 shares (Direct); 2025 Annual Restricted Stock Units — 1,695.05 shares (Direct); 2025 Elective Restricted Stock Units — 1,856.39 shares (Direct)

Footnotes (4)

F1. Each Restricted Stock Unit (RSU) represents the right to receive one share of Class A Common Stock.
F2. 2024 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2024. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.
F3. 2025 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2025. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.
F4. 2025 Elective RSUs were issued as dividend equivalents on holder's underlying Elective RSUs issued on July 1, 2025. The dividend equivalent Elective RSUs will vest concurrently with the vesting of the underlying Elective RSUs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 09/19/2025 - 05:33 PM

FAQ

What did Laila Worrell report on the Form 4 for Moelis & Co (MC)?

She reported acquisitions of dividend-equivalent restricted stock units for 2024 Annual RSUs, 2025 Annual RSUs and 2025 Elective RSUs on 09/18/2025.

Do the reported RSUs convert to shares of common stock?

Yes. The filing states each restricted stock unit represents the right to receive one share of Class A common stock.

When will these dividend-equivalent RSUs vest?

The dividend-equivalent RSUs will vest concurrently with the underlying RSUs to which they relate, per the filing.

Were any derivative transactions or stock sales reported?

No derivative securities, exercises, or dispositions are listed in the filing; only acquisitions of RSUs are reported.

Who signed the Form 4 and when?

The Form is signed by Osamu Watanabe as attorney-in-fact for Laila Worrell on 09/19/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Worrell Laila

(Last)

(First)

(Middle)

399 PARK AVE

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Moelis & Co [ MC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
2024 Annual Restricted Stock Units	09/18/2025		A		16.84	A	⁽¹⁾⁽²⁾	2,031.47	D
2025 Annual Restricted Stock Units	09/18/2025		A		14.05	A	⁽¹⁾⁽³⁾	1,695.05	D
2025 Elective Restricted Stock Units	09/18/2025		A		15.39	A	⁽¹⁾⁽⁴⁾	1,856.39	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents the right to receive one share of Class A Common Stock.

2. 2024 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2024. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.

3. 2025 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2025. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.

4. 2025 Elective RSUs were issued as dividend equivalents on holder's underlying Elective RSUs issued on July 1, 2025. The dividend equivalent Elective RSUs will vest concurrently with the vesting of the underlying Elective RSUs.

	/s/ Osamu Watanabe as attorney-in-fact for Laila Worrell	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR